Skip to content

Zishen Yutai Pill and aspirin in the prevention of preeclampsia: a ramdomized control trial

Zishen Yutai Pill and aspirin in the prevention of preeclampsia: a ramdomized control trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004020
Enrollment
Unknown
Registered
2020-10-16
Start date
2020-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Sponsors

Shenzhen Luohu People's Hospital (The Third Affiliated Hospital of Shenzhen University)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy; 2. Subjects who are 12-20 weeks pregnant; 3. The subjects who signed the informed consent form for clinical research; 4. High risk population of preeclampsia. Evaluation index: Has one or more of the following risk factors: History of preeclampsia; diabetes; Chronic hypertension; Chronic kidney disease; SLE or antiphospholipid antibody syndrome. Or with the following > = 2 risk factors: Primipara; BMI > 30kg / m2 before pregnancy,; The age of pregnant women was 35 years old; More than 10 years from the last pregnancy; The mother or sister had a history of preeclampsia; Previous pregnancies were smaller than gestational age infants; History of placental abruption; Family history of hypertension.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to aspirin or Zishenyutai pills; 2. Fetal malformation or chromosomal abnormality; 3. Patients with liver and kidney dysfunction or heart disease; 4. Subjects who have suffered from bleeding diseases such as gastric ulcer; 5. Mental patients; 6. Alcoholics or drug addicts; 7. Subjects who do not plan to have regular prenatal examination and delivery in the research unit.

Design outcomes

Primary

MeasureTime frame
incidence of preeclampsia;

Secondary

MeasureTime frame
incidence of preeclampsia that appear before 34 weeks of pregnancy;incidence of pregnancy hypertention;incidence of preterm birth;incidence of severe preeclampsia;

Countries

China

Contacts

Public ContactLai Baoling

Shenzhen Luohu Hospital (The Third Affiliated Hospital of Shenzhen University)

pauling925@126.com+86 13500051776

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026